Revoke Authorisation Upon Renunciation, Commerciodel Medicinal Product For Human Use "sumatriptan Momaja».

Original Language Title: Revoca, su rinuncia, dell'autorizzazione all'immissione in commerciodel medicinale per uso umano «Sumatriptan Momaja».

Read the untranslated law here: http://www.gazzettaufficiale.it/atto/serie_generale/caricaArticoloDefault/originario?atto.dataPubblicazioneGazzetta=2015-03-18&atto.codiceRedazionale=15A01885&elenco30giorni=false&atto.tipoProvvedimento=DECRETO

With no aRM-45/2015-4000 of February 18, 2015 's revoked, pursuant to art. 38, paragraph 9, of the Legislative Decree of April 24, 2006, no. 219, on renunciation of IPCA Laboratories UK Limited the marketing authorisation for the medicinal product in the boxes indicated below.
Medicine: SUMATRIPTAN MOMAJA.
Packaging: A.I.C. # 041084056 «100 mg film-coated tablets» 6 tablets in AL/AL strip;
A.I.C. # 041084043 «100 mg film-coated tablets» 4 tablets in AL/AL strip;
A.I.C. # 041084031 «50 mg film-coated tablets» 6 tablets in AL/AL strip;
A.I.C. # 041084029 «50 mg film-coated tablets» 4 tablets in AL/AL strip;
A.I.C. # 041084017 «50 mg film-coated tablets» 2 tablets in AL/AL strip.
If the distribution channel were present stocks of medicine revoked, in the course of validity, the same will be disposed of not later than 180 days after the date of publication of this determination.